Article Information
History
- September 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Si-Yue Jia, MPHa,*,
- Yuan-Bao Liu, Ph.Da,*,
- Qian He, Ph.Db,*,
- Hong-Xing Pan, MSca,
- Zheng-Lun Liang, Ph.Db,
- Juan Zhou, BMedc,
- Ying-Zi Pan, MPHd,
- Sheng Liu, BMede,
- Jing-Jing Wu, BMedf,
- Kun Yang, MPHg,
- Xuan-Xuan Zhang, Ph.Db,
- Yang Zhao, Ph.Dh,
- Si-Min Li, MSci,
- Lei Zhang, MPHa,
- Li Chen, BMedi,
- Ai-Hua Yao, BMedi,
- Meng-Yi Lu, Ph.Dh,
- Qun-Ying Mao, BMedb,†,
- Feng-Cai Zhu, MSca,h,i,† and
- Jing-Xin Li, Ph.Da,h,i,†
- aJiangsu Provincial Medical Innovation Center, National Health Commission Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine), Nanjing, China
- bDivision of Hepatitis and Enterovirus Vaccines, State Key Laboratory of Drug Regulatory Science, Institute of Biological Products, National Institutes for Food and Drug Control, Beijing, China
- cGaoxin (Gaogang) District Center for Disease Control and Prevention, Taizhou, China
- dWujin Center for Disease Control and Prevention, Changzhou, China
- eGanyu Center for Disease Control and Prevention, Lianyungang, China
- fSucheng Center for Disease Control and Prevention, Suqian, China
- gThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi, China
- hSchool of Public Health, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China
- iSchool of Public Health, Southeast University, Nanjing, China
- ↵†Corresponding Authors:
Prof Jingxin Li, Jiangsu Provincial Center for Disease Control and Prevention, 172 Jiangsu Rd., Nanjing 210009, China (jingxin42102209{at}126.com). Prof Fengcai Zhu, Jiangsu Provincial Center for Disease Control and Prevention, 172 Jiangsu Rd., Nanjing 210009, China (jszfc{at}vip.sina.com), Prof Qunying Mao, National Institutes for Food and Drug Control, 31 Huatuo Rd., Beijing 102600, China (maoqunying{at}126.com).
↵* These authors contributed equally: Siyue Jia, Yuanbao Liu and Qian He
Posted September 15, 2024.
Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults with hybrid immunity against COVID-19: a multicenter, partially randomized, platform trial in China
